150 related articles for article (PubMed ID: 25538961)
1. Salicylanilide diethyl phosphates as potential inhibitors of some mycobacterial enzymes.
Krátký M; Novotná E; Saxena S; Yogeeswari P; Sriram D; Švarcová M; Vinšová J
ScientificWorldJournal; 2014; 2014():703053. PubMed ID: 25538961
[TBL] [Abstract][Full Text] [Related]
2. Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase.
Krátký M; Vinšová J; Novotná E; Mandíková J; Wsól V; Trejtnar F; Ulmann V; Stolaříková J; Fernandes S; Bhat S; Liu JO
Tuberculosis (Edinb); 2012 Sep; 92(5):434-9. PubMed ID: 22765970
[TBL] [Abstract][Full Text] [Related]
3. Salicylanilide diethyl phosphates as cholinesterases inhibitors.
Krátký M; Štěpánková Š; Vorčáková K; Vinšová J
Bioorg Chem; 2015 Feb; 58():48-52. PubMed ID: 25462625
[TBL] [Abstract][Full Text] [Related]
4. Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase.
Krátký M; Vinšová J; Novotná E; Stolaříková J
Eur J Pharm Sci; 2014 Mar; 53():1-9. PubMed ID: 24333643
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
6. Ligand based virtual screening and biological evaluation of inhibitors of chorismate mutase (Rv1885c) from Mycobacterium tuberculosis H37Rv.
Agrawal H; Kumar A; Bal NC; Siddiqi MI; Arora A
Bioorg Med Chem Lett; 2007 Jun; 17(11):3053-8. PubMed ID: 17418569
[TBL] [Abstract][Full Text] [Related]
7. Salicylanilide diethyl phosphates: synthesis, antimicrobial activity and cytotoxicity.
Vinšová J; Kozic J; Krátký M; Stolaříková J; Mandíková J; Trejtnar F; Buchta V
Bioorg Med Chem; 2014 Jan; 22(2):728-37. PubMed ID: 24369840
[TBL] [Abstract][Full Text] [Related]
8. Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
Férriz JM; Vávrová K; Kunc F; Imramovský A; Stolaríková J; Vavríková E; Vinsová J
Bioorg Med Chem; 2010 Feb; 18(3):1054-61. PubMed ID: 20060303
[TBL] [Abstract][Full Text] [Related]
9. Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds.
Krátký M; Janďourek O; Baranyai Z; Novotná E; Stolaříková J; Bősze S; Vinšová J
Eur J Med Chem; 2019 Nov; 181():111578. PubMed ID: 31401536
[TBL] [Abstract][Full Text] [Related]
10. Design and Development of Mycobacterium tuberculosis Lysine ɛ-Aminotransferase Inhibitors for Latent Tuberculosis Infection.
Parthiban BD; Saxena S; Chandran M; Jonnalagadda PS; Yadav R; Srilakshmi RR; Perumal Y; Dharmarajan S
Chem Biol Drug Des; 2016 Feb; 87(2):265-74. PubMed ID: 26348876
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates.
Krátký M; Volková M; Novotná E; Trejtnar F; Stolaříková J; Vinšová J
Bioorg Med Chem; 2014 Aug; 22(15):4073-82. PubMed ID: 24953953
[TBL] [Abstract][Full Text] [Related]
12. Structure-guided design of thiazolidine derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Devi PB; Samala G; Sridevi JP; Saxena S; Alvala M; Salina EG; Sriram D; Yogeeswari P
ChemMedChem; 2014 Nov; 9(11):2538-47. PubMed ID: 25155986
[TBL] [Abstract][Full Text] [Related]
13. Design of Novel Mycobacterium tuberculosis Pantothenate Synthetase Inhibitors: Virtual Screening, Synthesis and In Vitro Biological Activities.
Devi PB; Jogula S; Reddy AP; Saxena S; Sridevi JP; Sriram D; Yogeeswari P
Mol Inform; 2015 Feb; 34(2-3):147-59. PubMed ID: 27490037
[TBL] [Abstract][Full Text] [Related]
14. Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.
Samala G; Nallangi R; Devi PB; Saxena S; Yadav R; Sridevi JP; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Aug; 22(15):4223-32. PubMed ID: 24953948
[TBL] [Abstract][Full Text] [Related]
15. The MM2QM tool for combining docking, molecular dynamics, molecular mechanics, and quantum mechanics.
Nowosielski M; Hoffmann M; Kuron A; Korycka-Machala M; Dziadek J
J Comput Chem; 2013 Apr; 34(9):750-6. PubMed ID: 23233437
[TBL] [Abstract][Full Text] [Related]
16. Advances in mycobacterial isocitrate lyase targeting and inhibitors.
Krátký M; Vinšová J
Curr Med Chem; 2012; 19(36):6126-37. PubMed ID: 23092127
[TBL] [Abstract][Full Text] [Related]
17. Andrographolide: A potent antituberculosis compound that targets Aminoglycoside 2'-N-acetyltransferase in Mycobacterium tuberculosis.
Prabu A; Hassan S; Prabuseenivasan ; Shainaba AS; Hanna LE; Kumar V
J Mol Graph Model; 2015 Sep; 61():133-40. PubMed ID: 26245695
[TBL] [Abstract][Full Text] [Related]
18. When inhibitors do not inhibit: critical evaluation of rational drug design targeting chorismate mutase from Mycobacterium tuberculosis.
Munack S; Leroux V; Roderer K; Ökvist M; van Eerde A; Gundersen LL; Krengel U; Kast P
Chem Biodivers; 2012 Nov; 9(11):2507-27. PubMed ID: 23161632
[TBL] [Abstract][Full Text] [Related]
19. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
[TBL] [Abstract][Full Text] [Related]
20. In vitro biological evaluation of new antimycobacterial salicylanilide-tuftsin conjugates.
Baranyai Z; Krátký M; Vosátka R; Szabó E; Senoner Z; Dávid S; Stolaříková J; Vinšová J; Bősze S
Eur J Med Chem; 2017 Jun; 133():152-173. PubMed ID: 28384546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
